A Study of Patients with a Positivie Bullous Pemphigoid Disease Test BP180 and BP230 but without a Clinical Diagnosis of Bullous Pemphigoid

Overview

About this study

The purpose of this study is to learn more about bullous pemphigoid disease testings called BP180 and BP230 in patients without a clinical diagnosis of bullous pemphigoid.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with positive BP 180 or BP 230 results
BPAG testing done in 2005-2015 time frame
Patients seen at Mayo Clinic
Adult population, age 18+
Individuals with consenting capacity
Patients with bullous pemphigoid as control group, patients without bullous pemphigoid as test group

Exclusion Criteria:

Anyone who don’t meet above exclusions.
Patients with ambiguous diagnosis regarding bullous pemphigoid
Vulnerable, protected populations

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Carilyn Wieland, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Carilyn Wieland, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials